Suppr超能文献

优化高血压控制的障碍。

Barriers to optimal hypertension control.

作者信息

Ogedegbe Gbenga

机构信息

Department of Medicine ,Columbia University, New York, NY 10032, USA.

出版信息

J Clin Hypertens (Greenwich). 2008 Aug;10(8):644-6. doi: 10.1111/j.1751-7176.2008.08329.x.

Abstract

There is an obvious gap in the translation of clinical trial evidence into practice with regards to optimal hypertension control. The three major categories of barriers to BP control are patient-related, physician-related, and medical environment/health care system factors. Patient-related barriers include poor medication adherence, beliefs about hypertension and its treatment, depression, health literacy, comorbidity, and patient motivation. The most pertinent is medication adherence, given its centrality to the other factors. The most salient physician-related barrier is clinical inertia--defined, as the failure of health care providers to initiate or intensify drug therapy in a patient with uncontrolled BP. The major reasons for clinical inertia are: 1) overestimation of the amount of care that physicians provide; 2) lack of training on how to attain target BP levels; and 3) clinicians' use of soft reasons to avoid treatment intensification by adopting a "wait until next visit" approach in response to patients' excuses.

摘要

在将临床试验证据转化为关于最佳高血压控制的实践方面,存在明显差距。血压控制的三大类障碍是与患者相关的、与医生相关的以及医疗环境/医疗保健系统因素。与患者相关的障碍包括药物依从性差、对高血压及其治疗的看法、抑郁、健康素养、合并症以及患者动机。鉴于其对其他因素的核心作用,最相关的是药物依从性。与医生相关的最突出障碍是临床惰性——定义为医疗保健提供者未能对血压未得到控制的患者启动或强化药物治疗。临床惰性的主要原因是:1)高估医生提供的护理量;2)缺乏关于如何达到目标血压水平的培训;3)临床医生使用软性理由,通过采取“等到下次就诊”的方法来回应患者的借口,从而避免强化治疗。

相似文献

1
Barriers to optimal hypertension control.
J Clin Hypertens (Greenwich). 2008 Aug;10(8):644-6. doi: 10.1111/j.1751-7176.2008.08329.x.
3
Identifying barriers to hypertension care: implications for quality improvement initiatives.
Dis Manag. 2008 Apr;11(2):71-7. doi: 10.1089/dis.2008.1120007.
4
Delegating responsibility from clinicians to nonprofessional personnel: the example of hypertension control.
J Am Board Fam Med. 2012 Mar-Apr;25(2):209-15. doi: 10.3122/jabfm.2012.02.100279.
6
When more is not better: treatment intensification among hypertensive patients with poor medication adherence.
Circulation. 2008 Jun 3;117(22):2884-92. doi: 10.1161/CIRCULATIONAHA.107.724104. Epub 2008 May 27.
7
The veterans' study to improve the control of hypertension (V-STITCH): design and methodology.
Contemp Clin Trials. 2005 Apr;26(2):155-68. doi: 10.1016/j.cct.2004.12.006.
8
Overcoming barriers to effective blood pressure control in patients with hypertension.
Curr Med Res Opin. 2006 Aug;22(8):1545-53. doi: 10.1185/030079906X120995.
9
Clinical inertia.
Ann Intern Med. 2001 Nov 6;135(9):825-34. doi: 10.7326/0003-4819-135-9-200111060-00012.
10
Reasons for therapeutic inertia when managing hypertension in clinical practice in non-Western countries.
J Hum Hypertens. 2009 Mar;23(3):151-9. doi: 10.1038/jhh.2008.117. Epub 2008 Sep 11.

引用本文的文献

5
Testing an Innovative Approach to Improve Hypertension Management at a Federally Qualified Health Center.
J Public Health Manag Pract. 2024;30:S46-S51. doi: 10.1097/PHH.0000000000001901. Epub 2024 Jun 12.
6
Planning the Implementation of a Multilevel Blood Pressure Control Intervention in Chicago: Community and Clinical Perspectives.
Ethn Dis. 2024 Apr 24;DECIPHeR(Spec Issue):60-67. doi: 10.18865/ed.DECIPHeR.60. eCollection 2023 Dec.
7
Update of the clinical guideline for hypertension diagnosis and treatment in Iran.
Clin Hypertens. 2024 Jun 1;30(1):13. doi: 10.1186/s40885-024-00269-6.
8
First Iranian guidelines for the diagnosis, management, and treatment of hyperlipidemia in adults.
J Res Med Sci. 2024 Mar 29;29:18. doi: 10.4103/jrms.jrms_318_23. eCollection 2024.

本文引用的文献

1
Barriers to hypertension control.
Am Heart J. 2005 May;149(5):785-94. doi: 10.1016/j.ahj.2005.01.047.
2
Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review.
J Hypertens. 2004 Oct;22(10):1849-55. doi: 10.1097/00004872-200410000-00002.
5
Patients' views about taking antihypertensive drugs: questionnaire study.
BMJ. 2003 Jun 14;326(7402):1314-5. doi: 10.1136/bmj.326.7402.1314.
7
Determinants of discontinuation of new courses of antihypertensive medications.
J Clin Epidemiol. 2002 Jul;55(7):728-35. doi: 10.1016/s0895-4356(02)00400-6.
8
Physician-related barriers to the effective management of uncontrolled hypertension.
Arch Intern Med. 2002 Feb 25;162(4):413-20. doi: 10.1001/archinte.162.4.413.
9
Clinical inertia.
Ann Intern Med. 2001 Nov 6;135(9):825-34. doi: 10.7326/0003-4819-135-9-200111060-00012.
10
Characteristics of patients with uncontrolled hypertension in the United States.
N Engl J Med. 2001 Aug 16;345(7):479-86. doi: 10.1056/NEJMoa010273.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验